India to Georgia: Protein Export Trade Route

The India to Georgia Protein corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $1.6M USD. The route is dominated by GETWELL PHARMA INDIA PRIVATE LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's protein manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $62.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with protein's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 10.5%, placing it at rank #6 among India's top protein export destinations globally.

On the import side, key buyers of Indian protein in Georgia include MERMISI LLC, MERMISI LLC , BIOPOLUS LTD and 2 others. MERMISI LLC is the single largest importer with 15 shipments valued at $1.2M USD.

India's protein exports to Georgia are driven primarily by a handful of large-scale manufacturers. GETWELL PHARMA INDIA PRIVATE LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Georgia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GETWELL PHARMA INDIA PRIVATE LIMITED, GETWELL PHARMACEUTICALS , FESTIVA PHARMA — together account for 99% of total trade value on this route. The average shipment value of $62.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as alpaxel 100mg(paclitaxel(protein bound particles)for injectable suspension)batchno.4gpnl04mfg.dt.05/2024 exp.dt.04/26 and alpaxel 100mg (paclitaxel(protein boundparticles)for injectable suspension)b.no.4gpnl03, mfg.dt. 04/2024,exp dt.03/2026, suggesting that buyers in Georgia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MERMISI LLC is the largest importer with 15 shipments worth $1.2M USD — representing 75% of all protein imports from India on this route.